Irritable bowel syndrome following gastroenteritis may last 4+ years in around half of those affected

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainIrritable bowel syndrome (IBS)—characterized by abdominal pain, bloating, and altered bowel habit—may last 4 or more years following a b

Gastroenterology July 17,2024 0

Irritable bowel syndrome following gastroenteritis may last 4+ years in around half of those affected

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainIrritable bowel syndrome (IBS)—characterized by abdominal pain, bloating, and altered bowel habit—may last 4 or more years following a b

Gastroenterology July 17,2024 0

Many breast cancer survivors do not receive genetic testing, despite being eligible

by Nicole Fawcett,University of MichiganCredit: Unsplash/CC0 Public DomainAs cancer treatment and survivorship care relies more on understanding the genetic make-up of an individual's tumor,

Oncology July 17,2024 0

Many breast cancer survivors do not receive genetic testing, despite being eligible

by Nicole Fawcett,University of MichiganCredit: Unsplash/CC0 Public DomainAs cancer treatment and survivorship care relies more on understanding the genetic make-up of an individual's tumor,

Oncology July 17,2024 0

Study uncovers unknown interaction between leukemic cells and immune cells

by Karl Landsteiner University of Health SciencesAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainThe protein STAT3 helps the immune system to recognize leukemic cells. This interact

Oncology July 17,2024 0

Study uncovers unknown interaction between leukemic cells and immune cells

by Karl Landsteiner University of Health SciencesAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainThe protein STAT3 helps the immune system to recognize leukemic cells. This interact

Oncology July 17,2024 0

Hormone therapy for breast cancer linked with lower dementia risk

byUniversity of PittsburghCredit: CC0 Public DomainHormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's dise

Oncology July 17,2024 0

Hormone therapy for breast cancer linked with lower dementia risk

byUniversity of PittsburghCredit: CC0 Public DomainHormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's dise

Oncology July 17,2024 0

Scientists develop potential stealth cancer therapy

by Yale Cancer Center/Smilow Cancer HospitalCredit:ACS Central Science(2024). DOI: 10.1021/acscentsci.4c00559Sneaking by cancer's defenses, by disguising tumor-fighting antibodies insi

Oncology July 17,2024 0

Scientists develop potential stealth cancer therapy

by Yale Cancer Center/Smilow Cancer HospitalCredit:ACS Central Science(2024). DOI: 10.1021/acscentsci.4c00559Sneaking by cancer's defenses, by disguising tumor-fighting antibodies insi

Oncology July 17,2024 0

Study reveals dual role of protein in cancer treatment

by Denise Heady,University of California, Los AngelesGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.114289Investigators at the UCLA Health Jonsson Comprehe

Oncology July 17,2024 0

Study reveals dual role of protein in cancer treatment

by Denise Heady,University of California, Los AngelesGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.114289Investigators at the UCLA Health Jonsson Comprehe

Oncology July 17,2024 0

Targeted drug treatment leads tumor cells to imitate viral infection, researchers discover

by Ari Navetta,Broad Institute of MIT and HarvardmIDH1 inhibition restores immune surveillance. Credit:Science(2024). DOI: 10.1126/science.adl6173A number of cancers, including certa

Oncology July 17,2024 0

Targeted drug treatment leads tumor cells to imitate viral infection, researchers discover

by Ari Navetta,Broad Institute of MIT and HarvardmIDH1 inhibition restores immune surveillance. Credit:Science(2024). DOI: 10.1126/science.adl6173A number of cancers, including certa

Oncology July 17,2024 0

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

Nephrology & Urology July 17,2024 0

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

Nephrology & Urology July 17,2024 0

The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

by Xia & He Publishing Inc.PRISMA flowchart for literature search and study selection, modified according to Page et al. Credit:Exploratory Research and Hypothesis in Medicine(2023). D

Oncology July 17,2024 0

The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

by Xia & He Publishing Inc.PRISMA flowchart for literature search and study selection, modified according to Page et al. Credit:Exploratory Research and Hypothesis in Medicine(2023). D

Oncology July 17,2024 0

New model could reduce reliance on chemotherapy

byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast

Oncology July 17,2024 0

New model could reduce reliance on chemotherapy

byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast

Oncology July 17,2024 0